Modified HFNC Oxygen in Patients Undergoing Bronchoscopy.

Modified High-flow Nasal Cannula Oxygen in Patients Undergoing Bronchoscopy.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02606188

Enrollment

812

Registered

2015-11-17

Start date

2015-11-30

Completion date

2019-12-31

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchoscopy,Oxygen

Keywords

Modified High-flow nasal cannula, Bronchoscopy, Oxygen therapy

Brief summary

The purpose of this study is to determine whether the Modified High-flow nasal cannula is effective in the oxygen of the patients undergoing bronchoscopy.

Interventions

DEVICEModified High-flow nasal cannula

Modified High-flow nasal cannula

DEVICEnasal cannula

Conventional oxygen therap

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

1. age more than 18 years old; 2. need for bronchoscopy for diagnosis purpose.

Exclusion criteria

1. peripheral arterial pulse oximetry was \< 90% 2. platelet count \< 60 × 109/L; 3. nasopharyngeal obstruction or blockage.

Design outcomes

Primary

Measure	Time frame
the proportion of patients SpO2 < 90% during bronchoscopy	1 hour

Secondary

Measure	Time frame
the operation time	1 hour

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026